{"transactions":[{"id":4630228,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-05T20:30:02.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":759,"derivative":{"exercise_price":31.59,"exercise_date":"2026-10-01","expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":759},"source":{"system":"sec-edgar","filing":"0001193125-26-414218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312526414218/ownership.xml","form_type":"4"}},{"id":671934,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":3583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.52,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":3583},"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671933,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":41927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":2773,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":41927},"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671932,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":3161,"price":37.5396,"value":118662.6756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $37.46 to $37.65. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671931,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":42349,"price":37.0925,"value":1570830.2825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $36.46 to $37.45. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":3161,"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671930,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":3583,"price":2.52,"value":9029.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."}],"balance_after":45510,"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671929,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":41927,"price":5.64,"value":236468.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."}],"balance_after":41927,"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":714487,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-06T20:30:27.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":627,"derivative":{"exercise_price":38.48,"exercise_date":"2026-07-01","expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":627},"source":{"system":"sec-edgar","filing":"0001193125-26-296249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312526296249/ownership.xml","form_type":"4"}},{"id":741195,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":1,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:27.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267665","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312526267665/ownership.xml","form_type":"4"}},{"id":741217,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:25.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312526267663/ownership.xml","form_type":"4"}},{"id":741806,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:23.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000119312526267662/ownership.xml","form_type":"4"}},{"id":741194,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39158,"kind":"person","name":"Shegog Todd","position":1,"cik":"0001714564","reported_name":"Shegog Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:10.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312526267670/ownership.xml","form_type":"4"}},{"id":741478,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:06.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267667","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526267667/ownership.xml","form_type":"4"}},{"id":741696,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39276,"kind":"person","name":"Ros Matthew","position":1,"cik":"0001673802","reported_name":"Ros Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:03.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267666","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673802/000119312526267666/ownership.xml","form_type":"4"}},{"id":767488,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":45118,"kind":"person","name":"Robbins Andrew R","position":1,"cik":"0001590157","reported_name":"Robbins Andrew R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-21T20:30:06.000Z","date":"2026-05-19","kind":"gift","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 19, 2026, Mr. Robbins transferred 160,000 shares of common stock to a family trust for estate planning purposes."}],"balance_after":160000,"source":{"system":"sec-edgar","filing":"0001193125-26-234578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590157/000119312526234578/ownership.xml","form_type":"4"}},{"id":767487,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":45118,"kind":"person","name":"Robbins Andrew R","position":1,"cik":"0001590157","reported_name":"Robbins Andrew R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-21T20:30:06.000Z","date":"2026-05-19","kind":"gift","planned":false,"acquired":false,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 19, 2026, Mr. Robbins transferred 160,000 shares of common stock to a family trust for estate planning purposes."}],"balance_after":497503,"source":{"system":"sec-edgar","filing":"0001193125-26-234578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590157/000119312526234578/ownership.xml","form_type":"4"}},{"id":815660,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:01:03.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":686,"derivative":{"exercise_price":35.24,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":686},"source":{"system":"sec-edgar","filing":"0001193125-26-142082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312526142082/ownership.xml","form_type":"4"}},{"id":823926,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-04-01T01:30:12.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. On March 31, 2026, the Reporting Persons converted 28,000 shares of Series A Convertible Preferred Stock into 7,000,000 shares of Common Stock for no cash consideration, in accordance with the Certificate of Designations for the Series A Convertible Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. On March 31, 2026, the Reporting Persons converted 28,000 shares of Series A Convertible Preferred Stock into 7,000,000 shares of Common Stock for no cash consideration, in accordance with the Certificate of Designations for the Series A Convertible Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. On March 31, 2026, the Reporting Persons converted 28,000 shares of Series A Convertible Preferred Stock into 7,000,000 shares of Common Stock for no cash consideration, in accordance with the Certificate of Designations for the Series A Convertible Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP (\"Fund II\"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":39414,"derivative":{"underlying":"Common Stock","underlying_shares":7000000},"source":{"system":"sec-edgar","filing":"0001104659-26-038057","document":"tm2610819-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000110465926038057/tm2610819-2_4seq1.xml","form_type":"4"}},{"id":823925,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T01:30:12.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":7000000,"price":34.66,"value":242620000.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP (\"Fund II\"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":5503418,"source":{"system":"sec-edgar","filing":"0001104659-26-038057","document":"tm2610819-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000110465926038057/tm2610819-2_4seq1.xml","form_type":"4"}},{"id":823924,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T01:30:12.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":7000000,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. On March 31, 2026, the Reporting Persons converted 28,000 shares of Series A Convertible Preferred Stock into 7,000,000 shares of Common Stock for no cash consideration, in accordance with the Certificate of Designations for the Series A Convertible Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP (\"Fund II\"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":12503418,"source":{"system":"sec-edgar","filing":"0001104659-26-038057","document":"tm2610819-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000110465926038057/tm2610819-2_4seq1.xml","form_type":"4"}},{"id":933155,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-23T01:09:39.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":3500000,"price":36.4,"value":127400000.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP (\"Fund II\"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":5503418,"source":{"system":"sec-edgar","filing":"0001104659-26-005924","document":"tm263873-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000110465926005924/tm263873-2_4seq1.xml","form_type":"4"}},{"id":950034,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:01:03.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":643,"derivative":{"exercise_price":34.74,"exercise_date":"2026-01-01","expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":643},"source":{"system":"sec-edgar","filing":"0001193125-26-002367","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312526002367/ownership.xml","form_type":"4"}},{"id":956987,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70732,"kind":"person","name":"Green John L.","position":1,"cik":"0001709773","reported_name":"Green John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-30T21:01:06.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":77000,"price":38.68,"value":2978360.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.51 to $38.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":131834,"source":{"system":"sec-edgar","filing":"0001193125-25-337051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525337051/ownership.xml","form_type":"4"}},{"id":956986,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70731,"kind":"person","name":"Sachs Jessica","position":1,"cik":"0001782545","reported_name":"Sachs Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-30T21:01:05.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":82642,"price":38.7,"value":3198245.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.53 to $38.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":133938,"source":{"system":"sec-edgar","filing":"0001193125-25-337050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525337050/ownership.xml","form_type":"4"}},{"id":956985,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-30T21:01:03.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":90000,"price":38.74,"value":3486600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.51 to $39.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":140002,"source":{"system":"sec-edgar","filing":"0001193125-25-337049","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525337049/ownership.xml","form_type":"4"}},{"id":957216,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-30T16:01:08.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":65000,"price":38.7,"value":2515500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.52 to $38.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":109398,"source":{"system":"sec-edgar","filing":"0001193125-25-337052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525337052/ownership.xml","form_type":"4"}},{"id":961811,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T21:01:12.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":65000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001193125-25-326776","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326776/ownership.xml","form_type":"4"}},{"id":961810,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:12.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":139998,"price":39.45,"value":5522921.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":230002,"source":{"system":"sec-edgar","filing":"0001193125-25-326776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326776/ownership.xml","form_type":"4"}},{"id":961809,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:12.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":370000,"source":{"system":"sec-edgar","filing":"0001193125-25-326776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326776/ownership.xml","form_type":"4"}},{"id":961808,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:12.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001193125-25-326776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326776/ownership.xml","form_type":"4"}},{"id":961829,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":45118,"kind":"person","name":"Robbins Andrew R","position":1,"cik":"0001590157","reported_name":"Robbins Andrew R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T21:01:10.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":245000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":245000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":245000},"source":{"system":"sec-edgar","filing":"0001193125-25-326775","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1590157/000119312525326775/ownership.xml","form_type":"4"}},{"id":961828,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":45118,"kind":"person","name":"Robbins Andrew R","position":1,"cik":"0001590157","reported_name":"Robbins Andrew R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:10.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":367497,"price":39.45,"value":14497756.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":657503,"source":{"system":"sec-edgar","filing":"0001193125-25-326775","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590157/000119312525326775/ownership.xml","form_type":"4"}},{"id":961827,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":45118,"kind":"person","name":"Robbins Andrew R","position":1,"cik":"0001590157","reported_name":"Robbins Andrew R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:10.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":840000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":1025000,"source":{"system":"sec-edgar","filing":"0001193125-25-326775","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590157/000119312525326775/ownership.xml","form_type":"4"}},{"id":961826,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":45118,"kind":"person","name":"Robbins Andrew R","position":1,"cik":"0001590157","reported_name":"Robbins Andrew R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:10.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."}],"balance_after":185000,"source":{"system":"sec-edgar","filing":"0001193125-25-326775","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590157/000119312525326775/ownership.xml","form_type":"4"}},{"id":961807,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70731,"kind":"person","name":"Sachs Jessica","position":1,"cik":"0001782545","reported_name":"Sachs Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T21:01:04.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":65000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001193125-25-326773","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326773/ownership.xml","form_type":"4"}},{"id":961806,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70731,"kind":"person","name":"Sachs Jessica","position":1,"cik":"0001782545","reported_name":"Sachs Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:04.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":154716,"price":39.45,"value":6103546.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":216580,"source":{"system":"sec-edgar","filing":"0001193125-25-326773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326773/ownership.xml","form_type":"4"}},{"id":961805,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70731,"kind":"person","name":"Sachs Jessica","position":1,"cik":"0001782545","reported_name":"Sachs Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:04.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":371296,"source":{"system":"sec-edgar","filing":"0001193125-25-326773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326773/ownership.xml","form_type":"4"}},{"id":961804,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70731,"kind":"person","name":"Sachs Jessica","position":1,"cik":"0001782545","reported_name":"Sachs Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:04.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."}],"balance_after":51296,"source":{"system":"sec-edgar","filing":"0001193125-25-326773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326773/ownership.xml","form_type":"4"}},{"id":961803,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70732,"kind":"person","name":"Green John L.","position":1,"cik":"0001709773","reported_name":"Green John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T21:01:03.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":65000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001193125-25-326771","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326771/ownership.xml","form_type":"4"}},{"id":961802,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70732,"kind":"person","name":"Green John L.","position":1,"cik":"0001709773","reported_name":"Green John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:03.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":145007,"price":39.45,"value":5720526.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":208834,"source":{"system":"sec-edgar","filing":"0001193125-25-326771","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326771/ownership.xml","form_type":"4"}},{"id":961801,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70732,"kind":"person","name":"Green John L.","position":1,"cik":"0001709773","reported_name":"Green John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:03.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":353841,"source":{"system":"sec-edgar","filing":"0001193125-25-326771","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326771/ownership.xml","form_type":"4"}},{"id":961800,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70732,"kind":"person","name":"Green John L.","position":1,"cik":"0001709773","reported_name":"Green John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:01:03.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."}],"balance_after":53841,"source":{"system":"sec-edgar","filing":"0001193125-25-326771","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312525326771/ownership.xml","form_type":"4"}},{"id":962212,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T16:01:08.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":65000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001193125-25-326774","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000119312525326774/ownership.xml","form_type":"4"}},{"id":962211,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:08.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":94800,"price":39.45,"value":3739860.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":216650,"source":{"system":"sec-edgar","filing":"0001193125-25-326774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000119312525326774/ownership.xml","form_type":"4"}},{"id":962210,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:08.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":214000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":311450,"source":{"system":"sec-edgar","filing":"0001193125-25-326774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000119312525326774/ownership.xml","form_type":"4"}},{"id":962209,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:08.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,602 shares of common stock acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on June 30, 2025."}],"balance_after":97450,"source":{"system":"sec-edgar","filing":"0001193125-25-326774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000119312525326774/ownership.xml","form_type":"4"}},{"id":962048,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T16:01:06.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":55000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001193125-25-326772","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525326772/ownership.xml","form_type":"4"}},{"id":962047,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:06.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":125602,"price":39.45,"value":4954998.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":174398,"source":{"system":"sec-edgar","filing":"0001193125-25-326772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525326772/ownership.xml","form_type":"4"}},{"id":962046,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:06.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001193125-25-326772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525326772/ownership.xml","form_type":"4"}},{"id":962045,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:06.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001193125-25-326772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000119312525326772/ownership.xml","form_type":"4"}},{"id":1024066,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T20:16:22.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":1642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":1642,"derivative":{"exercise_price":14.13,"exercise_date":"2025-10-01","expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":1642},"source":{"system":"sec-edgar","filing":"0001193125-25-230215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000119312525230215/ownership.xml","form_type":"4"}},{"id":1087877,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-14T20:30:37.000Z","date":"2025-07-10","kind":"purchase","planned":false,"acquired":true,"shares":2777777,"price":9,"value":24999993.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP (\"Fund II\"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":9003418,"source":{"system":"sec-edgar","filing":"0001104659-25-067758","document":"tm2520886-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000110465925067758/tm2520886-1_4seq1.xml","form_type":"4"}},{"id":1094238,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:15:43.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":3314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3314,"derivative":{"exercise_price":7.22,"exercise_date":"2025-07-01","expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":3314},"source":{"system":"sec-edgar","filing":"0000950170-25-092976","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017025092976/ownership.xml","form_type":"4"}},{"id":1120896,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:25:51.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017025082374/ownership.xml","form_type":"4"}},{"id":1121475,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:24:15.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC  (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000095017025082368/ownership.xml","form_type":"4"}},{"id":1121297,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39276,"kind":"person","name":"Ros Matthew","position":1,"cik":"0001673802","reported_name":"Ros Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:21:56.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082365","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673802/000095017025082365/ownership.xml","form_type":"4"}},{"id":1120885,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39158,"kind":"person","name":"Shegog Todd","position":1,"cik":"0001714564","reported_name":"Shegog Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:21:25.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017025082364/ownership.xml","form_type":"4"}},{"id":1120884,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":1,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:19:21.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC  (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082349","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017025082349/ownership.xml","form_type":"4"}},{"id":1121143,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:17:57.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000095017025082348/ownership.xml","form_type":"4"}},{"id":1178799,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T20:05:21.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3788,"derivative":{"exercise_price":5.79,"exercise_date":"2025-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0000950170-25-050374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017025050374/ownership.xml","form_type":"4"}},{"id":1294206,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70732,"kind":"person","name":"Green John L.","position":1,"cik":"0001709773","reported_name":"Green John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T22:03:58.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":270000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0000950170-25-009271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017025009271/ownership.xml","form_type":"4"}},{"id":1294205,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T21:58:18.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":270000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0000950170-25-009263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017025009263/ownership.xml","form_type":"4"}},{"id":1294193,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70731,"kind":"person","name":"Sachs Jessica","position":1,"cik":"0001782545","reported_name":"Sachs Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T21:56:20.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":270000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0000950170-25-009258","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017025009258/ownership.xml","form_type":"4"}},{"id":1294259,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":45118,"kind":"person","name":"Robbins Andrew R","position":1,"cik":"0001590157","reported_name":"Robbins Andrew R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T21:56:09.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":915000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":915000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":915000},"source":{"system":"sec-edgar","filing":"0000950170-25-009257","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590157/000095017025009257/ownership.xml","form_type":"4"}},{"id":1294626,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T17:00:07.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":240000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0000950170-25-009266","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000095017025009266/ownership.xml","form_type":"4"}},{"id":1294515,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T16:55:46.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":230000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0000950170-25-009256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000095017025009256/ownership.xml","form_type":"4"}},{"id":1302754,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-15T07:00:04.000Z","date":"2025-01-14","kind":"purchase","planned":false,"acquired":true,"shares":43750,"price":7.598,"value":332412.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $7.53 to $7.60.  Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,398 shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on December 31, 2024."}],"balance_after":45848,"source":{"system":"sec-edgar","filing":"0000950170-25-005630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000095017025005630/ownership.xml","form_type":"4"}},{"id":1313449,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T21:21:26.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":2785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2785,"derivative":{"exercise_price":7.8,"exercise_date":"2025-01-01","expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":2785},"source":{"system":"sec-edgar","filing":"0000950170-25-001210","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017025001210/ownership.xml","form_type":"4"}},{"id":1393704,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T20:14:19.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":2034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2034,"derivative":{"exercise_price":10.75,"exercise_date":"2024-10-01","expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":2034},"source":{"system":"sec-edgar","filing":"0000950170-24-111468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024111468/ownership.xml","form_type":"4"}},{"id":1462091,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-02T20:31:16.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2462,"derivative":{"exercise_price":8.94,"exercise_date":"2024-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0000950170-24-080555","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024080555/ownership.xml","form_type":"4"}},{"id":1480845,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:18:50.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC  (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000095017024073238/ownership.xml","form_type":"4"}},{"id":1480718,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39276,"kind":"person","name":"Ros Matthew","position":1,"cik":"0001673802","reported_name":"Ros Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:14:34.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673802/000095017024073235/ownership.xml","form_type":"4"}},{"id":1480217,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:14:15.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073234","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024073234/ownership.xml","form_type":"4"}},{"id":1480186,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2225,"kind":"person","name":"Harwin Peter Evan","position":1,"cik":"0001663607","reported_name":"Harwin Peter Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:11:20.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC  (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024073231/ownership.xml","form_type":"4"}},{"id":1480185,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39158,"kind":"person","name":"Shegog Todd","position":1,"cik":"0001714564","reported_name":"Shegog Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:07:34.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024073228/ownership.xml","form_type":"4"}},{"id":1480434,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:06:46.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000095017024073226/ownership.xml","form_type":"4"}},{"id":1481695,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-06-13T01:01:59.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Following receipt of the Requisite Stockholder Approval, each share of Series B Preferred Stock automatically converted into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 0% and 19.9%) of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 5, 2024, Issuer's stockholders approved an amendment to Issuer's Certificate of Incorporation to increase the number of authorized shares of Common Stock from 150,000,000 to 300,000,000 (the \"Requisite Stockholder Approval\"). Accordingly, pursuant to the terms of the Certificate of Designations of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock, 1,500 shares of Series B Convertible Preferred Stock, par value $0.001 per share (the \"Series B Preferred Stock\"), held by Fairmount Healthcare Fund II LP (\"Fund II\") were converted into 1,500,000 shares of Common Stock, effective at 5:00 pm ET on June 10, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Following receipt of the Requisite Stockholder Approval, each share of Series B Preferred Stock automatically converted into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 0% and 19.9%) of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Following receipt of the Requisite Stockholder Approval, each share of Series B Preferred Stock automatically converted into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 0% and 19.9%) of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fund II. They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0000950170-24-072639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024072639/ownership.xml","form_type":"4"}},{"id":1481694,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T01:01:59.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":1500000,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 5, 2024, Issuer's stockholders approved an amendment to Issuer's Certificate of Incorporation to increase the number of authorized shares of Common Stock from 150,000,000 to 300,000,000 (the \"Requisite Stockholder Approval\"). Accordingly, pursuant to the terms of the Certificate of Designations of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock, 1,500 shares of Series B Convertible Preferred Stock, par value $0.001 per share (the \"Series B Preferred Stock\"), held by Fairmount Healthcare Fund II LP (\"Fund II\") were converted into 1,500,000 shares of Common Stock, effective at 5:00 pm ET on June 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 5, 2024, Issuer's stockholders approved an amendment to Issuer's Certificate of Incorporation to increase the number of authorized shares of Common Stock from 150,000,000 to 300,000,000 (the \"Requisite Stockholder Approval\"). Accordingly, pursuant to the terms of the Certificate of Designations of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock, 1,500 shares of Series B Convertible Preferred Stock, par value $0.001 per share (the \"Series B Preferred Stock\"), held by Fairmount Healthcare Fund II LP (\"Fund II\") were converted into 1,500,000 shares of Common Stock, effective at 5:00 pm ET on June 10, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fund II. They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":6225641,"source":{"system":"sec-edgar","filing":"0000950170-24-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024072639/ownership.xml","form_type":"4"}},{"id":1499392,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T16:03:03.000Z","date":"2024-05-25","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest 25% on the first anniversary of May 25, 2024, with the remainder vesting in equal monthly installments through May 25, 2028, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":525000,"derivative":{"exercise_price":8.22,"expiration_date":"2034-05-25","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0000950170-24-065900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000095017024065900/ownership.xml","form_type":"4"}},{"id":1552709,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-02T22:21:13.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":3213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3213,"derivative":{"exercise_price":6.9,"exercise_date":"2024-04-01","expiration_date":"2034-04-01","underlying":"Common Stock","underlying_shares":3213},"source":{"system":"sec-edgar","filing":"0000950170-24-040496","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024040496/ownership.xml","form_type":"4"}},{"id":1555885,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-04-01T22:19:19.000Z","date":"2024-03-28","kind":"other","planned":false,"acquired":true,"shares":11914,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 28, 2024, in connection with the wind down of Fairmount Healthcare Fund LP (\"Fund I\"), all shares of Common Stock and Series A Convertible Preferred Stock held by Fund I were transferred to Fairmount Healthcare Fund II LP (\"Fund II\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fund II. They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":67414,"derivative":{"underlying":"Common Stock","underlying_shares":2978500},"source":{"system":"sec-edgar","filing":"0000950170-24-039588","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024039588/ownership.xml","form_type":"4"}},{"id":1555884,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-04-01T22:19:19.000Z","date":"2024-03-28","kind":"other","planned":false,"acquired":false,"shares":11914,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 28, 2024, in connection with the wind down of Fairmount Healthcare Fund LP (\"Fund I\"), all shares of Common Stock and Series A Convertible Preferred Stock held by Fund I were transferred to Fairmount Healthcare Fund II LP (\"Fund II\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund GP LLC have voting power and investment power over the securities held by Fund I. They disclaim beneficial ownership of securities held by Fund I for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2978500},"source":{"system":"sec-edgar","filing":"0000950170-24-039588","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024039588/ownership.xml","form_type":"4"}},{"id":1555883,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T22:19:19.000Z","date":"2024-03-28","kind":"other","planned":false,"acquired":true,"shares":286851,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 28, 2024, in connection with the wind down of Fairmount Healthcare Fund LP (\"Fund I\"), all shares of Common Stock and Series A Convertible Preferred Stock held by Fund I were transferred to Fairmount Healthcare Fund II LP (\"Fund II\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 28, 2024, in connection with the wind down of Fairmount Healthcare Fund LP (\"Fund I\"), all shares of Common Stock and Series A Convertible Preferred Stock held by Fund I were transferred to Fairmount Healthcare Fund II LP (\"Fund II\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fund II. They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":4725641,"source":{"system":"sec-edgar","filing":"0000950170-24-039588","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024039588/ownership.xml","form_type":"4"}},{"id":1555882,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T22:19:19.000Z","date":"2024-03-28","kind":"other","planned":false,"acquired":false,"shares":286851,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 28, 2024, in connection with the wind down of Fairmount Healthcare Fund LP (\"Fund I\"), all shares of Common Stock and Series A Convertible Preferred Stock held by Fund I were transferred to Fairmount Healthcare Fund II LP (\"Fund II\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 28, 2024, in connection with the wind down of Fairmount Healthcare Fund LP (\"Fund I\"), all shares of Common Stock and Series A Convertible Preferred Stock held by Fund I were transferred to Fairmount Healthcare Fund II LP (\"Fund II\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund GP LLC have voting power and investment power over the securities held by Fund I. They disclaim beneficial ownership of securities held by Fund I for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-039588","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024039588/ownership.xml","form_type":"4"}},{"id":1637461,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-02-16T23:43:37.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":7500,"value":11250000.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series B Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.99% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock and Series B Preferred Stock were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series B Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.99% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series B Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.99% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series B Preferred Stock held by Fairmount Healthcare Fund II LP (\"Fund II\"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0000950170-24-016610","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024016610/ownership.xml","form_type":"4"}},{"id":1637460,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-16T23:43:37.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":1166666,"price":7.5,"value":8749995.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock and Series B Preferred Stock were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series B Preferred Stock held by Fairmount Healthcare Fund II LP (\"Fund II\"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":4438790,"source":{"system":"sec-edgar","filing":"0000950170-24-016610","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024016610/ownership.xml","form_type":"4"}},{"id":1670663,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70730,"kind":"person","name":"Robinson John Edward","position":1,"cik":"0001856514","reported_name":"Robinson John Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T21:36:41.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":300000,"derivative":{"exercise_price":4.63,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-24-007436","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024007436/ownership.xml","form_type":"4"}},{"id":1670662,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70731,"kind":"person","name":"Sachs Jessica","position":1,"cik":"0001782545","reported_name":"Sachs Jessica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T21:20:10.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":300000,"derivative":{"exercise_price":4.63,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-24-007415","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024007415/ownership.xml","form_type":"4"}},{"id":1670667,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":45118,"kind":"person","name":"Robbins Andrew R","position":1,"cik":"0001590157","reported_name":"Robbins Andrew R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T21:20:02.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":1100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":1100000,"derivative":{"exercise_price":4.63,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":1100000},"source":{"system":"sec-edgar","filing":"0000950170-24-007414","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590157/000095017024007414/ownership.xml","form_type":"4"}},{"id":1670661,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70732,"kind":"person","name":"Green John L.","position":1,"cik":"0001709773","reported_name":"Green John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T21:17:30.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":300000,"derivative":{"exercise_price":4.63,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-24-007410","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000095017024007410/ownership.xml","form_type":"4"}},{"id":1670971,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":70747,"kind":"person","name":"Kearns Evan","position":1,"cik":"0001745285","reported_name":"Kearns Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T16:27:09.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":255000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":255000,"derivative":{"exercise_price":4.63,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":255000},"source":{"system":"sec-edgar","filing":"0000950170-24-007422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745285/000095017024007422/ownership.xml","form_type":"4"}},{"id":1686969,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T21:24:05.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":3298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3298,"derivative":{"exercise_price":6.24,"exercise_date":"2024-01-02","expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":3298},"source":{"system":"sec-edgar","filing":"0000950170-24-001886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017024001886/ownership.xml","form_type":"4"}},{"id":1687854,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39276,"kind":"person","name":"Ros Matthew","position":1,"cik":"0001673802","reported_name":"Ros Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T21:20:41.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":3051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":3051,"derivative":{"exercise_price":6.24,"exercise_date":"2024-01-02","expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":3051},"source":{"system":"sec-edgar","filing":"0000950170-24-001876","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673802/000095017024001876/ownership.xml","form_type":"4"}},{"id":1767498,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39276,"kind":"person","name":"Ros Matthew","position":1,"cik":"0001673802","reported_name":"Ros Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-03T20:56:48.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":2170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2170,"derivative":{"exercise_price":9.55,"exercise_date":"2023-10-02","expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":2170},"source":{"system":"sec-edgar","filing":"0000950170-23-051615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673802/000095017023051615/ownership.xml","form_type":"4"}},{"id":1766581,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-03T20:51:38.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":2345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":2345,"derivative":{"exercise_price":9.55,"exercise_date":"2023-10-02","expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":2345},"source":{"system":"sec-edgar","filing":"0000950170-23-051604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017023051604/ownership.xml","form_type":"4"}},{"id":1835191,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":31986,"kind":"person","name":"Ferrante Karen Jean","position":1,"cik":"0001598502","reported_name":"Ferrante Karen Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T20:53:33.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":1884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":1884,"derivative":{"exercise_price":11.96,"exercise_date":"2023-07-03","expiration_date":"2033-07-03","underlying":"Common Stock","underlying_shares":1884},"source":{"system":"sec-edgar","filing":"0000950170-23-031704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598502/000095017023031704/ownership.xml","form_type":"4"}},{"id":1836214,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39276,"kind":"person","name":"Ros Matthew","position":1,"cik":"0001673802","reported_name":"Ros Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T20:53:24.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":1743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":1743,"derivative":{"exercise_price":11.96,"exercise_date":"2023-07-03","expiration_date":"2033-07-03","underlying":"Common Stock","underlying_shares":1743},"source":{"system":"sec-edgar","filing":"0000950170-23-031702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673802/000095017023031702/ownership.xml","form_type":"4"}},{"id":1856860,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":2222,"kind":"person","name":"Fairmount Funds Management LLC","position":1,"cik":"0001802528","reported_name":"Fairmount Funds Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2023-06-13T20:07:36.000Z","date":"2023-06-09","kind":"purchase","planned":false,"acquired":true,"shares":800000,"price":12,"value":9600000.0,"ownership":{"direct":false,"nature":"Fairmount Healthcare Fund II LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series A Preferred Stock held by Fairmount Healthcare Fund II LP (\"Fund II\"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein."}],"balance_after":3272124,"source":{"system":"sec-edgar","filing":"0001104659-23-070794","document":"tm2318495-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000110465923070794/tm2318495-1_4seq1.xml","form_type":"4"}},{"id":1862081,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:58:20.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":36700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders."}],"balance_after":36700,"derivative":{"exercise_price":11.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":36700},"source":{"system":"sec-edgar","filing":"0000899243-23-014905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000089924323014905/doc4.xml","form_type":"4"}},{"id":1862566,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:52:44.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":36700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC  (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":36700,"derivative":{"exercise_price":11.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":36700},"source":{"system":"sec-edgar","filing":"0000899243-23-014903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000089924323014903/doc4.xml","form_type":"4"}}],"next_cursor":"2023-06-08T20:52:44.000000Z,1862566"}